VanEck Pharmaceutical ETF
ETFYour view on PPH

VanEck Pharmaceutical ETF
ETFVanEckSentiment
AUM (USD)
$1.09B
Expense Ratio
0.36%
Yield (TTM)
1.82%
Holdings
26
Sentiment
Overview
What the fund invests in, who runs it, and what it costs.
VanEck Pharmaceutical ETF (PPH) is an Equity fund from VanEck, listed since 2011, with $1.1B in assets under management, a 0.36% expense ratio and a NAV of $121.58 USD.
Overview for VanEck Pharmaceutical ETF
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
About this fund
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceutical…
Price Chart
Market price history and trading volume.
Key Facts
Cost, yield, size, and the fund's reference data.
Expense Ratio
0.36%
Yield (TTM)
1.82%
AUM
$1.09B
Fund Details
Expense Ratio
0.36%
Dividend Yield (TTM)
1.82%
Assets Under Management
$1.09B
NAV
$121.58 USD
Holdings
26
Average Volume
302.9K
Inception Date
December 20, 2011
Asset Class
Equity
Fund Issuer
VanEck
Domicile
US
ISIN
US92189F6925
CUSIP
92189F692
NAV Currency
USD
Expense Ratio
0.36%
Dividend Yield (TTM)
1.82%
Assets Under Management
$1.09B
NAV
$121.58 USD
Holdings
26
Average Volume
302.9K
Inception Date
December 20, 2011
Asset Class
Equity
Fund Issuer
VanEck
Domicile
US
ISIN
US92189F6925
CUSIP
92189F692
NAV Currency
USD
Distributions · last 12 months
Quarterly · 4 payments
| Ex-date | Paid | Amount |
|---|---|---|
| Oct 1, 2026 | Oct 6, 2026 | $0.36 |
| Jul 1, 2026 | Jul 7, 2026 | $0.6248 |
| Apr 1, 2026 | Apr 7, 2026 | $0.8441 |
| Dec 29, 2025 | Dec 31, 2025 | $0.3106 |
| Total, 12 months | $2.14 a share | |
Dividend yield (TTM) 1.82% = $2.14 paid per share in the 12 months to Nov 20, 2026 ÷ the $117.87 price. Past distributions; future payments can differ.
Sectors
How the fund's assets are split across sectors.
- 1Healthcare100.0%
Top sector
Healthcare
Top weight
100.0%
Top 3 weight
100.0%
Holdings
The securities the fund owns, by weight.
Concentration
Total Holdings
27
Top 10 Weight
71.29%
Top Holding
LLY
Top Weight
22.95%
Total Holdings
27
Top 10 Weight
71.29%
Top Holding
LLY
Top Weight
22.95%
Comparables
Funds similar to this one.
Comparable funds
- BBHVanEck Biotech ETFEquity0.35%$536M25
- BKMCBNY Mellon US Mid Cap Core Equity ETFEquity0.04%$657M403
- CXSEWisdomTree China ex-State-Owned Enterprises FundEmerging Markets Equity0.32%$380M205
- EBILongview Advantage ETFEquity0.34%$685M0
- FYCFirst Trust Small Cap Growth AlphaDEX FundSmall/Micro Cap Equity0.70%$1.4B264
- IHEiShares US Pharmaceuticals ETFEquity0.37%$1.7B52
- NUKZRange Nuclear Renaissance Index ETFEquity0.85%$591M52
- OSEAHarbor International Compounders ETF (OSEA)Equity0.55%$374M30
More VanEck ETFs
- WARPVanEck Space ETFEquity0.50%$37M21
- XMPTVanEck CEF Muni Income ETFMulti-Asset3.40%$210M39
- VSOLVanEck Solana ETFAlternatives0.30%$16M1
Fund Holders
Institutions that own shares of this fund.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.